<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259472/" ref="ordinalpos=331&amp;ncbi_uid=6961704&amp;link_uid=PMC4259472" image-link="/pmc/articles/PMC4259472/figure/pone-0113830-g006/" class="imagepopup">Figure 6. Notch <span class="highlight" style="background-color:">pathway</span> was regulated in Oridonin in HUVECs..  From: Oridonin Inhibits Tumor Growth and Metastasis through Anti-Angiogenesis by Blocking the Notch <span class="highlight" style="background-color:">Signaling</span>. </a></div><br /><div class="p4l_captionBody">(A) DAPT blocked Notch gene transcription and Notch activity. (B) and (C) Oridonin remarkably inhibited expression of key ligands, receptors and downstream genes (Fig. 6B, Q-PCR) and proteins (Fig. 6C, Western blot) involved in the Jagged-Notch Signaling Pathway. (D) Schematic diagram of Oridonin inhibiting tumor growth and tumor metastasis by regulating the Jagged-Notch signaling pathway in HUVECs.</div></div>